NZ515999A - Biologically active materials - Google Patents

Biologically active materials

Info

Publication number
NZ515999A
NZ515999A NZ515999A NZ51599900A NZ515999A NZ 515999 A NZ515999 A NZ 515999A NZ 515999 A NZ515999 A NZ 515999A NZ 51599900 A NZ51599900 A NZ 51599900A NZ 515999 A NZ515999 A NZ 515999A
Authority
NZ
New Zealand
Prior art keywords
biologically active
active materials
polymer
drug conjugate
dextrin
Prior art date
Application number
NZ515999A
Other languages
English (en)
Inventor
Ruth Duncan
Dale Hreczuk-Hirst
Lisa German
Original Assignee
Ml Lab Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9914187.1A external-priority patent/GB9914187D0/en
Priority claimed from GBGB9930252.3A external-priority patent/GB9930252D0/en
Application filed by Ml Lab Plc filed Critical Ml Lab Plc
Publication of NZ515999A publication Critical patent/NZ515999A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A61K51/065—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules conjugates with carriers being macromolecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NZ515999A 1999-06-18 2000-06-19 Biologically active materials NZ515999A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9914187.1A GB9914187D0 (en) 1999-06-18 1999-06-18 Biologically active materials
GBGB9930252.3A GB9930252D0 (en) 1999-12-22 1999-12-22 Biologically active molecules
PCT/GB2000/002216 WO2000078355A2 (en) 1999-06-18 2000-06-19 Biologically active materials

Publications (1)

Publication Number Publication Date
NZ515999A true NZ515999A (en) 2004-03-26

Family

ID=26315678

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ515999A NZ515999A (en) 1999-06-18 2000-06-19 Biologically active materials

Country Status (11)

Country Link
US (1) US6818630B1 (https=)
EP (1) EP1198253A2 (https=)
JP (1) JP2003504312A (https=)
AU (1) AU783886B2 (https=)
CA (1) CA2374548A1 (https=)
HK (1) HK1047884A1 (https=)
IL (1) IL146795A0 (https=)
MX (1) MXPA01013276A (https=)
NO (1) NO20016147L (https=)
NZ (1) NZ515999A (https=)
WO (1) WO2000078355A2 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8106098B2 (en) 1999-08-09 2012-01-31 The General Hospital Corporation Protein conjugates with a water-soluble biocompatible, biodegradable polymer
EP1315777B1 (en) 2000-09-06 2007-10-31 AP Pharma, Inc. Degradable polyacetal polymers
DE10112825A1 (de) 2001-03-16 2002-10-02 Fresenius Kabi De Gmbh HESylierung von Wirkstoffen in wässriger Lösung
DE10129369C1 (de) 2001-06-21 2003-03-06 Fresenius Kabi De Gmbh Wasserlösliches, einen Aminozucker aufweisendes Antibiotikum in Form eines Pol ysaccharid-Konjugats
AU2003209227A1 (en) 2002-01-14 2003-07-30 The General Hospital Corporation Biodegradable polyketal polymers and methods for their formation and use
DE10209821A1 (de) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung von Proteinen an ein modifiziertes Polysaccharid
US8030459B2 (en) 2002-07-19 2011-10-04 The General Hospital Corporation Oxime conjugates and methods for their formation and use
ATE409048T1 (de) 2002-10-08 2008-10-15 Fresenius Kabi De Gmbh Pharmazeutisch aktive oligosaccharid-conjugate
US7947261B2 (en) * 2003-05-23 2011-05-24 Nektar Therapeutics Conjugates formed from polymer derivatives having particular atom arrangements
WO2005014655A2 (en) 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein
AU2004270251B2 (en) * 2003-09-05 2011-03-31 The General Hospital Corporation Polyacetal drug conjugates as release system
WO2010068759A1 (en) 2008-12-10 2010-06-17 Mersana Therapeutics, Inc. Pharmaceutical formulations of biodegradable biocompatible camptothecin-polymer conjugates
KR102366322B1 (ko) 2020-07-31 2022-02-22 주식회사 다산네트웍스 전기자전거 주행시스템

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0477931B1 (en) 1990-09-28 1994-08-17 Mercian Corporation Novel adriamycin derivatives
WO1995005199A1 (en) 1993-08-19 1995-02-23 Dextran Products Limited Pharmaceutical preparation and a process for making same
IT1281877B1 (it) 1995-05-10 1998-03-03 Fidia Advanced Biopolymers Srl Sali di metalli pesanti di succinil derivati dell'acido ialuronico e loro impiego come potenziali agenti terapeutici
AU8025998A (en) * 1997-06-12 1998-12-30 Ml Laboratories Plc Biologically active materials

Also Published As

Publication number Publication date
WO2000078355A3 (en) 2002-02-21
HK1047884A1 (zh) 2003-03-14
IL146795A0 (en) 2002-07-25
US6818630B1 (en) 2004-11-16
AU783886B2 (en) 2005-12-22
NO20016147D0 (no) 2001-12-17
MXPA01013276A (es) 2002-06-04
CA2374548A1 (en) 2000-12-28
EP1198253A2 (en) 2002-04-24
AU5413000A (en) 2001-01-09
NO20016147L (no) 2002-01-29
JP2003504312A (ja) 2003-02-04
WO2000078355A2 (en) 2000-12-28

Similar Documents

Publication Publication Date Title
NZ515999A (en) Biologically active materials
MY129356A (en) Electrospun pharmaceutical compositions
BG106747A (en) Novel composition and use
BG106030A (en) Pharmaceutical composition
AU6845300A (en) Novel multilayered material bearing a biologically active agent and the preparation thereof
DE69721481D1 (de) Wirkstoffformulierungen mit verzögerter freisetzung
DE69835201D1 (en) Neoglycoproteine
AU2001288829A1 (en) Degradable polyacetal polymers
GR3030732T3 (en) Pharmaceutical compositions including a drug, a cross-linked polymeric substance, an oil, and a surface active agent.
DK1061900T3 (da) Dermale præparater
DE69424441D1 (de) (2,4-disulfophenyl) n-tertiär butyl nitron, seine salze und ihre verwendung als pharmazeutische radikalfänger
DE69931925D1 (de) 2-chinolonen enthaltende arzneimittel
ATE395906T1 (de) Träger in partikelform zur verbesserung der oral- absorption von wikstoffen
DE69815094D1 (de) 2-(iminoethyl)-aminophenyl - derivate, deren herstellung, deren verwendung als medikamente und diese enthaltende pharmazeutische zubereitungen
EA004302B9 (ru) β-КАРБОЛИНОВЫЕ ЛЕКАРСТВЕННЫЕ ПРОДУКТЫ
AU5376500A (en) Functional poly-alpha-aminoacid derivatives useful for the modification of biologically active materials and their application
AU8025998A (en) Biologically active materials
WO2003074033A8 (en) Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
MXPA03005221A (es) Composicion farmaceutica de dronedarona para administracion parenteral.
CA2350659A1 (en) Pharmaceutical composition for modified release insulin sensitiser
WO1996040074A3 (en) Device for releasing aggregation-stabilized, biologically active agent
DE69609501D1 (de) Zusammensetzung mit natriumstärkeglycolat als grundlagenmaterial und daraus hergestellte produkte
AU3550100A (en) Biodegradable, injectable oligomer-polymer composition
ATE158172T1 (de) Pulverförmige pharmazeutische zusammensetzung
ATE219665T1 (de) Dosisformen und deren verwendungen

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)